Q1 2021

Filed May 17, 2021 · 10-Q · 47 days after period end · 0001437749-21-012379

Q1 2021 · 10-Q

Revenue

$571.00K

+30.1% vs Q1 2020

Net Income

-$1.88M

N/M vs Q1 2020

EPS Diluted

-$0.01

N/M vs Q1 2020

Gross Profit$232,000+29.6%

Operating Income

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	$571.00K	$439.00K	$364.00K	$364.00K
Net Income	-$1.88M	-$2.62M	-$2.75M	-$2.43M
EPS Diluted	-$0.01	-$0.01	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR